TISSUE RESECTION SYSTEMS AND METHODS FOR DIAGNOSTIC AND THERAPEUTIC IMPLEMENTATION
A method for removing tissues may comprise disposing a tissue resection device at a target tissue site, causing the tissue resection device to resect a core of tissue from the target tissue site, removing the core of tissue from the body, wherein the removing the core of tissue from the body creates a core cavity at the target tissue site.
1 . A method for coring tissue, the method comprising:
determining a location of a tissue lesion at a tissue site of a body;
navigating an instrument based on a location of the tissue lesion;
coupling the instrument to the tissue lesion or adjacent the tissue lesion;
configuring access to the tissue site;
introducing a tissue resection device to the tissue site;
using the tissue resection device to create a core of tissue;
removing the core of tissue from the body to create a tissue cavity;
analyzing the tissue core sample;
sealing the tissue cavity;
removing some or all instrumentation; and
closing tissue access points.
2 . The method of claim 1 , wherein the tissue site comprise lung tissue.
3 . The method of claim 1 , wherein the navigating the instrument defines a pathway and wherein the introducing the tissue resection device is based on the pathway.
4 . The method of claim 1 , wherein the introducing the tissue resection device is implemented using at least a portion of the instrument.
5 . The method of claim 1 , wherein the core of tissue comprises at least a portion of the tissue lesion.
6 . The method of claim 1 , wherein the determining the location of a tissue lesion comprises using an imaging system.
7 . The method of claim 6 , wherein the imaging system comprises one or more of computer tomography, ultrasound, magnetic resonance imaging, endoscope, visual, electromagnetic, or X-ray.
8 . The method of claim 1 , wherein the navigating an instrument to the tissue lesion comprising using a robotic system.
9 . The method of claim 1 , wherein the navigating an instrument to the tissue lesion comprising using one or more of computer tomography, ultrasound, electromagnetic navigation, or fluoroscopic navigation.
10 . The method of claim 1 , wherein the configuring access to the tissue site comprises using one or more of chest wall incision blades, tissue dilation, a trocar, or an open incision.
11 . The method of claim 1 , wherein the analyzing the tissue core sample comprises using one or more of rapid on-site evaluation, histology, immunohistochemistry, electron microscopy, flow cytometry, image cytometry, polymerase chain reaction, gene expression microarrays, fluorescent in situ hybridization, genetic sequencing, atomic force microscopy, or surface enhanced Ramen spectroscopy.
12 . A method for coring tissue, the method comprising:
determining a location of a tissue lesion at a tissue site of a body;
navigating an instrument based on a location of the tissue lesion;
coupling the instrument to the tissue lesion or adjacent the tissue lesion;
introducing a tissue resection device to the tissue site;
using the tissue resection device to create a core of tissue;
removing the core of tissue from the body to create a tissue cavity;
analyzing the tissue core sample;
sealing the tissue cavity; and
removing some or all instrumentation.
13 . The method of claim 12 , wherein the tissue site comprise lung tissue.
14 . The method of claim 12 , wherein the navigating the instrument defines a pathway and wherein the introducing the tissue resection device is based on the pathway.
15 . The method of claim 12 , wherein the introducing the tissue resection device is implemented using at least a portion of the instrument.
16 . The method of claim 12 , wherein the core of tissue comprises at least a portion of the tissue lesion.
17 . The method of claim 12 , wherein the determining the location of a tissue lesion comprises using an imaging system.
18 . The method of claim 17 , wherein the imaging system comprises one or more of computer tomography, ultrasound, magnetic resonance imaging, endoscope, visual, electromagnetic, or X-ray.
19 . The method of claim 12 , wherein the navigating an instrument to the tissue lesion comprising using a robotic system.
20 . The method of claim 12 , wherein the navigating an instrument to the tissue lesion comprising using one or more of computer tomography, ultrasound, electromagnetic navigation, or fluoroscopic navigation.
21 . The method of claim 12 , further comprising configuring access to the tissue site wherein the configuring access to the tissue site comprises using one or more of one or more of chest wall incision blades, tissue dilation, a trocar, or an open incision.
22 . The method of claim 12 , wherein the analyzing the tissue core sample comprises using one or more of rapid on-site evaluation, histology, immunohistochemistry, electron microscopy, flow cytometry, image cytometry, polymerase chain reaction, gene expression microarrays, fluorescent in situ hybridization, genetic sequencing, atomic force microscopy, or surface enhanced Ramen spectroscopy.
23 . A method for coring tissue, the method comprising:
determining the location of a tissue lesion;
navigating an instrument based on a location of the tissue lesion;
coupling the instrument to the tissue lesion or adjacent the tissue lesion;
configuring access to a tissue site comprising the tissue lesion;
introducing a tissue resection device to the tissue site;
using the tissue resection device to create a core of tissue;
removing the core of tissue from the body, thereby defining at least a portion of a tissue cavity;
analyzing the tissue core sample;
performing a diagnostic procedure using at least the tissue core sample;
sealing the tissue cavity;
removing some or all instrumentation; and
closing tissue access points.
24 . The method of claim 23 , wherein the core of tissue comprises at least a portion of the tissue lesion.
25 . The method of claim 23 , wherein the determining the location of a tissue lesion comprises using an imaging system.
26 . The method of claim 25 , wherein the imaging system comprises one or more of computer tomography, ultrasound, magnetic resonance imaging, endoscope, visual, electromagnetic, or X-ray.
27 . The method of claim 23 , wherein the navigating an instrument to the tissue lesion comprising using a robotic system.
28 . The method of claim 23 , wherein the navigating an instrument to the tissue lesion comprising using one or more of computer tomography, ultrasound, electromagnetic navigation, or fluoroscopic navigation.
29 . The method of claim 23 , wherein the configuring access to the tissue site comprises using one or more of one or more of chest wall incision blades, tissue dilation, a trocar, or an open incision.
30 . The method of claim 23 , wherein the analyzing the tissue core sample comprises using one or more of rapid on-site evaluation, histology, immunohistochemistry, electron microscopy, flow cytometry, image cytometry, polymerase chain reaction, gene expression microarrays, fluorescent in situ hybridization, genetic sequencing, atomic force microscopy, or surface enhanced Ramen spectroscopy.
31 . A method for coring tissue, the method comprising:
determining the location of a tissue lesion;
navigating an instrument based on a location of the tissue lesion;
coupling the instrument to the tissue lesion or adjacent the tissue lesion;
configuring access to a tissue site comprising the tissue lesion;
introducing a tissue resection device to the tissue site;
using the tissue resection device to create a core of tissue;
removing the core of tissue from the body, thereby defining at least a portion of a tissue cavity;
analyzing the tissue core sample;
performing therapeutic management of tissue;
sealing the tissue cavity;
removing some or all instrumentation; and
closing tissue access points.
32 . The method of claim 31 , wherein the core of tissue comprises at least a portion of the tissue lesion.
33 . The method of claim 31 , wherein the determining the location of a tissue lesion comprises using an imaging system.
34 . The method of claim 33 , wherein the imaging system comprises one or more of computer tomography, ultrasound, magnetic resonance imaging, endoscope, visual, electromagnetic, or X-ray.
35 . The method of claim 31 , wherein the navigating an instrument to the tissue lesion comprising using a robotic system.
36 . The method of claim 31 , wherein the navigating an instrument to the tissue lesion comprising using one or more of computer tomography, ultrasound, electromagnetic navigation, or fluoroscopic navigation.
37 . The method of claim 31 , wherein the configuring access to the tissue site comprises using one or more of one or more of chest wall incision blades, tissue dilation, a trocar, or an open incision.
38 . The method of claim 31 , wherein the analyzing the tissue core sample comprises using one or more of rapid on-site evaluation, histology, immunohistochemistry, electron microscopy, flow cytometry, image cytometry, polymerase chain reaction, gene expression microarrays, fluorescent in situ hybridization, genetic sequencing, atomic force microscopy, or surface enhanced Ramen spectroscopy.
39 . The method of claim 31 , wherein the performing therapeutic management of tissue comprises one or more of ablation, chemotherapy, hydrogel-based controlled drug delivery, or photodynamic therapy.
40 . The method of claim 31 , wherein the performing therapeutic management of tissue comprises using a scaffold system.
41 . The method of claim 31 , wherein the performing therapeutic management of tissue comprises hyperthermia of cored tissue site.
42 . The method of claim 31 , wherein the performing therapeutic management of tissue is based on the analyzing the tissue core sample.
43 . The method of claim 31 , wherein the performing therapeutic management of tissue is implemented on benign tissue.
44 . The method of claim 31 , wherein the performing therapeutic management of tissue is implemented on malignant tissue.
45 . A method for coring tissue, the method comprising:
introducing a tissue resection device to a tissue site;
using the tissue resection device to create a core of tissue;
removing at least a portion of the core of tissue from the body, thereby defining at
least a portion of a tissue cavity;
analyzing the tissue core sample; and
sealing the tissue cavity.
46 . The method of claim 45 , further comprising using an imaging system to determine the location of a tissue lesion within the tissue site.
47 . The method of claim 46 , wherein the imaging system comprises one or more of computer tomography, ultrasound, magnetic resonance imaging, endoscope, visual, electromagnetic, or X-ray.
48 . The method of claim 45 , further comprising using a robotic system to navigate an instrument to the tissue site.
49 . The method of claim 45 , further comprising using one or more of computer tomography, ultrasound, electromagnetic navigation, or fluoroscopic navigation to navigate an instrument to the tissue site.
50 . The method of claim 45 , wherein the analyzing the tissue core sample comprises using one or more of rapid on-site evaluation, histology, immunohistochemistry, electron microscopy, flow cytometry, image cytometry, polymerase chain reaction, gene expression microarrays, fluorescent in situ hybridization, genetic sequencing, atomic force microscopy, or surface enhanced Ramen spectroscopy.
51 . The method of claim 45 , further comprising determining a diagnostic using at least the tissue core sample.
52 . The method of claim 45 , further comprising performing therapeutic management of tissue.
53 . The method of claim 45 , further comprising performing therapeutic management of benign tissue.
54 . The method of claim 45 , further comprising performing therapeutic management of malignant tissue.
55 . The method of claim 54 , wherein the performing therapeutic management of malignant tissue comprises ablation.
56 . The method of claim 54 , wherein the performing therapeutic management of tissue comprises one or more of ablation, chemotherapy, hydrogel-based controlled drug delivery, or photodynamic therapy.
57 . The method of claim 54 , wherein the performing therapeutic management of malignant tissue comprises using a scaffold system.
58 . The method of claim 54 , wherein the performing therapeutic management of malignant tissue comprises hyperthermia of cored tissue site.
59 . A method for coring tissue, the method comprising:
determining the location of a tissue lesion;
navigating an instrument based on a location of the tissue lesion;
coupling the instrument to the tissue lesion or adjacent the tissue lesion;
introducing a tissue resection device to a tissue site;
using the tissue resection device to create a core of tissue;
removing the core of tissue from the body, thereby defining at least a portion of a tissue cavity;
analyzing the tissue core sample;
performing therapeutic management of tissue;
sealing the tissue cavity; and
removing some or all instrumentation.
60 . The method of claim 59 , wherein the core of tissue comprises at least a portion of the tissue lesion.
61 . The method of claim 59 , wherein the determining the location of a tissue lesion comprises using an imaging system.
62 . The method of claim 61 , wherein the imaging system comprises one or more of computer tomography, ultrasound, magnetic resonance imaging, endoscope, visual, electromagnetic, or X-ray.
63 . The method of claim 59 , wherein the navigating an instrument to the tissue lesion comprising using a robotic system.
64 . The method of claim 59 , wherein the navigating an instrument to the tissue lesion comprising using one or more of computer tomography, ultrasound, electromagnetic navigation, or fluoroscopic navigation.
65 . The method of claim 59 , further comprising configuring access to the tissue site wherein the configuring access to the tissue site comprises using one or more of one or more of chest wall incision blades, tissue dilation, a trocar, or an open incision.
66 . The method of claim 59 , wherein the analyzing the tissue core sample comprises using one or more of rapid on-site evaluation, histology, immunohistochemistry, electron microscopy, flow cytometry, image cytometry, polymerase chain reaction, gene expression microarrays, fluorescent in situ hybridization, genetic sequencing, atomic force microscopy, or surface enhanced Ramen spectroscopy.
67 . The method of claim 59 , wherein the performing therapeutic management of tissue comprises one or more of ablation, chemotherapy, hydrogel-based controlled drug delivery, or photodynamic therapy.
68 . The method of claim 59 , wherein the performing therapeutic management of tissue comprises using a scaffold system.
69 . The method of claim 59 , wherein the performing therapeutic management of tissue comprises hyperthermia of cored tissue site.
70 . The method of claim 59 , wherein the performing therapeutic management of tissue is based on the analyzing the tissue core sample.
71 . The method of claim 59 , wherein the performing therapeutic management of tissue is implemented on benign tissue.
72 . The method of claim 59 , wherein the performing therapeutic management of tissue is implemented on malignant tissue.